#46
|
|||
|
|||
Pediatric Rheumatology Online Journal ñ îòêðûòûì àðõèâîì ñ 2003 ïî 2006 ãîäû [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Ñ óâàæåíèåì, Âàëåðèé Âàëåðüåâè÷ Ñàìîéëåíêî |
#47
|
|||
|
|||
Öåíòð Êîíòðîëÿ Çàáîëåâàíèé (ÑØÀ, Àòëàíòà)
Ìåæäóíàðîäíûå ïóòåøåñòâèÿ ñ ìëàäåíöàìè è ìàëûìè äåòüìè íà àíãëèéñêîì [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] International Travel with Infants and Young Children (Infant - ðåáåíîê îò 0 äî 23 ìåñ) îñíîâíûå îáñóæäàåìûå ïðîáëåìû: - Äèàðåÿ è îáåçâîæèâàíèå - Ìàëÿðèÿ - Íàñåêîìûå - Èíôèöèðîâàíèå ïðè êîíòàêòå ñ ïåñêîì - Óêóñû æèâîòíûõ è áåøåíñòâî - Âîçäóøíûé ïåðåëåò - Íåñ÷àñòíûå ñëó÷àè è òðàâìû - Ãîðíàÿ áîëåçíü - Âîçäåéñòâèå ñîëíöà - Ñòðàõîâêà è îáåñïå÷åíèå áåçîïàñíîñòè ïóòåøåñòâèÿ ñ ðåáåíêîì òàì æå [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Breastfeeding and Travel Ãðóäíîå âñêàðìëèâàíèå è ïóòåøåñòâèå (íà àíãë) - Ïðèíÿòèå ðåøåíèÿ íàñ÷åò àâ ïóòåøåñòâèè - Ïîäãîòîâêà ê ïóòåøåñòâèþ â ïåðèîä à- Ïîääåðæêà ëàêòàöèè â òå÷åíèå ïóòåøåñòâèÿ - Èììóíèçàöèÿ è ìåäèêàìåíòû äëÿ êîðìÿùåé ìàòåðè - Ïóòåøåñòâèå ñ ãðóäíûì ìëàäåíöåì |
#48
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
SUMMER SAFETY TIPS from the American Academy of Pediatrics (AAP) FUN IN THE SUN (çàáàâû íà ñîëíöå) HEAT STRESS IN EXERCISING CHILDREN (òåïëîâîé ñòðåññ ó àêòèâíûõ äåòåé) POOL SAFETY (áåçîïàñíîñòü â áàññåéíå) BUG SAFETY (áåçîïàñíîñòü îò íàñåêîìûõ) PLAYGROUND SAFETY (áåçîïàñíîñòü íà èãðîâîé ïëîùàäêå) BICYCLE SAFETY (áåçîïàñíîñòü íà âåëîñèïåäå) SKATEBOARD, SCOOTER, IN-LINE SKATING AND HEELYS SAFETY (áåçîïàñíîñòü íà ñêåéòáîðäå, ñêóòåðå, ðîëèêàõ) LAWN MOWER SAFETY (áåçîïàñíîñòü ñâÿçàííàÿ ñ ãàçîíîêîñèëêîé) |
#49
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Êëèíèêà Ìåéî Air travel with infant: Is it safe? |
#50
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
PEDIATRICS Vol. 123 No. 3 March 2009, pp. 1003-1010 Antibiotic Use in Children Is Associated With Increased Risk of Asthma BACKGROUND. Antibiotic exposure in early childhood is a possible contributor to the increasing asthma prevalence in industrialized countries. Although a number of published studies have tested this hypothesis, the results have been conflicting. OBJECTIVE. To explore the association between antibiotic exposure before 1 year of age and development of childhood asthma. METHODS. Using administrative data, birth cohorts from 1997 to 2003 were evaluated (N = 251817). Antibiotic exposure was determined for the first year of life. After the first 24 months of life, the incidence of asthma was determined in both those exposed and not exposed to antibiotics in the first 12 months of life. Cox proportional hazards models were used to adjust for potential confounders and determine the hazard ratios associated with antibiotic exposure for the development of asthma. RESULTS. Antibiotic exposure in the first year of life was associated with a small risk of developing asthma in early childhood after adjusting for gender, socioeconomic status at birth, urban or rural address at birth, birth weight, gestational age, delivery method, frequency of physician visits, hospital visit involving surgery, visits to an allergist, respirologist, or immunologist, congenital anomalies, and presence of otitis media, acute, or chronic bronchitis, and upper and lower respiratory tract infections during the first year of life. As the number of courses of antibiotics increased, this was associated with increased asthma risk, with the highest risk being in children who received >4 courses. All antibiotics were associated with an increased risk of developing asthma, with the exception of sulfonamides. CONCLUSIONS. This study provides evidence that the use of antibiotics in the first year of life is associated with a small risk of developing asthma, and this risk increases with the number of courses of antibiotics prescribed. |
#51
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Pediatrics |
#52
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ìåãàñïðàâî÷íèê äëÿ ïåäèàòðà. Ìàëî áóêâ, ìíîãî èíôîðìàöèè. |
|
#53
|
|||
|
|||
Textbook of pediatric emergency procedures (1997)
äîñòóïíà ïî÷òè ïîëíîòåêñòîâî íà Ãóãëáóêñ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#54
|
|||
|
|||
New WHO guidance to improve use of medicines for children
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Model Formulary for Children provides information on how to use over 240 essential medicines WHO Model Formulary for Children [pdf 2.96Mb] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] 18 JUNE 2010 | GENEVA -- The first ever WHO Model Formulary for Children released by the WHO provides information on how to use over 240 essential medicines for treating illness and disease in children from 0 to 12 years of age. This means that for the first time medical practitioners worldwide have access to standardized information on the recommended use, dosage, adverse effects, and contraindications of these medicines for use in children. A number of individual countries have developed their own formularies over the years, but until now there was no single comprehensive guide to using medicines in children for all countries. Based on global evidence The new Formulary is based on the best global evidence available as to which medicines should be used to treat specific conditions, how they should be administered and in what dose. Accurate dosing of medicines for use in children is essential, particularly those between 0-12 months. A dosing error in a child this small can have devastating results. How the Formulary will help The Formulary will help health-care providers prescribe the right medicine, in the right formulation and the right dose. It also highlights what precautions to take, what adverse reactions may need to be monitored, and what kind of interactions may occur if the patient is taking other medications. For åxample, the Formulary indicates that ibuprofen, which is frequently given to children to treat pain, can have negative interactions when taken with any one of twenty-one listed medicines. It is also important to give this medicine with or after food. In the case of medicines to treat malaria or HIV, the Formulary highlights the need for better fixed dose combinations - several medicines in one pill - for effective and safe treatment in children. Currently very few fixed dose combinations exist for children; just one anti-malarial and two antiretrovirals to treat children with HIV. In developing the Formulary a number of areas were identified where more research is needed to provide better treatment for children, such as child appropriate antibiotics to treat pneumonia and specific medicines for neonatal care. Importance of the Formulary Each year 8.8 million children under five die (2008 data). Many of these deaths are caused by diseases which could be avoided with the use of safe essential medicines formulated appropriately for children. These include diarrhoea and pneumonia as well as conditions such as severe bacterial infections in newborns. |
#55
|
||||
|
||||
Ãàéä ïî ôåáðèëüíûì ñóäîðîãàì
Öèòàòà:
...Ñâåæàÿ âåðñèÿ ãàéäëàéíà îò 2008ã, íà îñíîâå âûøåóêàçàííîãî äîêóìåíòà 1999ã, çäåñü: [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ïîïûòêà ïåðåâîäà çäåñü: http://forums.rusmedserv.com/blog.php?b=432#comment1486
__________________
Òîëüêî ïîìíèòå: ôîðóì - íå çàìåíà î÷íîìó âðà÷ó, à ëå÷åíèå ïî èíòåðíåòó - ÷ðåâàòî ñìåðòüþ îò îïå÷àòêè. Ñ óâàæåíèåì, Ñåðãåé Àëåêñàíäðîâè÷. |
#56
|
||||
|
||||
Ïóáëèêóþ çäåñü ðÿä ññûëîê îò êîëëåãè cfif23.
ñ ïåðåâîäîì íà ðóññêèé ÿçûê: Öèòàòà:
Öèòàòà:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Òîëüêî ïîìíèòå: ôîðóì - íå çàìåíà î÷íîìó âðà÷ó, à ëå÷åíèå ïî èíòåðíåòó - ÷ðåâàòî ñìåðòüþ îò îïå÷àòêè. Ñ óâàæåíèåì, Ñåðãåé Àëåêñàíäðîâè÷. |